Aerobic Versus Anaerobic Exercise on Immune Functions and Disease Severity in Patients With COVID-19
1 other identifier
interventional
30
1 country
1
Brief Summary
Participants were assigned randomly into two groups, aerobic exercise and resistance exercise groups. All participants in both groups followed the WHO guidelines of quarantine and used standardized medications given by the physician according to the Turkish Ministry of Health guidelines, including the Hydroxyclorocin Sulphate 200 Mg Film Tablet (Plaquenil 200 Mg Film Tablet). The dose was 2 times/ day, 200Mg/time, for 5 days. Besides, the aerobic exercise group performed moderate-intensity aerobic exercises for 40 min/ 3 sessions/week, 40 minute/session, and the resistance exercise groups 40 min/ 3 sessions/week, 40 minute/session.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable covid19
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 6, 2021
CompletedFirst Posted
Study publicly available on registry
August 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedAugust 19, 2021
August 1, 2021
9 months
August 6, 2021
August 12, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Immune Biomarkers
Blood sample collection,Saliva sample collection,Wisconsin Upper Respiratory Symptom Survey
10 Months
Study Arms (2)
Aerobic Exercise Group
EXPERIMENTALModerate Intensity Aerobic Exercises
Resistance Exercise Group
EXPERIMENTALModerate Intensity Resistance Exercises
Interventions
Moderate aerobic and resistance exercise programe
Eligibility Criteria
You may qualify if:
- the patient has a recent mild or moderate COVID-19 with no or low-grade fever 99.5- 100.94 °F (37.5-38.3 °C). Mild COVID-19 included that the patient has symptoms of acute upper respiratory tract infection (fever, cough, myalgia, runny nose, fatigue, sore throat, sneezing) or gastrointestinal symptoms (nausea, vomiting, abdominal pain, diarrhea). Moderate grade of COVID 19 included that the participant has pneumonia (cough, frequent fever) with no obvious hypoxemia, the presence of lesions on chest CT
You may not qualify if:
- that patient was not hospitalized and has moderate or high-grade fever \<100.94 °F (\<38.3 °C) or other chronic diseases such as heart problems, hypertension or diabetes. Women how were using contraceptives were excluded due to contraceptives decrease immune functions and might affect the subjectivity to autoimmune disorders with marked increases in risk for various autoimmune disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Motaz Alawna
Istanbul, 3, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 6, 2021
First Posted
August 11, 2021
Study Start
January 1, 2021
Primary Completion
October 1, 2021
Study Completion
October 1, 2021
Last Updated
August 19, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share